Document is current
Any future updates will be listed below
-
Authors
Ariyaratne, Dinuka
Jayadas, Tibutius Thanesh Pramanayagam
Jeewandara, Chandima
Senadheera, Bhagya
De Silva, Malithi
Gomes, Laksiri
Bary, Farha
Syenina, Ayesa
Ranasinghe, Diyanath
Kuruppu, Heshan
Wijewickrama, Ananda
Ooi, Eng Eong
Malavige, Gathsaurie Neelika
-
Funding
Funding for this research was provided by:
National Medical Research Council
National Institute of Allergy and Infectious Diseases (5U01AI151788-02)
World Bank Group
- License Information
-
More Information
Article History
Received: 22 May 2025
Accepted: 24 November 2025
First Online: 26 December 2025
Declarations
:
: Ethics approval was obtained from the Ethics Review Committee of the University of Sri Jayewardenepura (12/15 and 58/19). All participants gave informed written consent. This study has adhered to the Declaration of Helsinki .
: Not applicable.
: EEO has served in advisory capacities on dengue for Sanofi Pasteur, Takeda Pharmaceuticals, MSD, Johnson & Johnson and Novartis. GNM has served in advisory capacities on dengue for Johnson & Johnson, Novartis, Takeda and Abbott. The other authors have no competing interests to declare.
